Guenthner T M, Cai D, Wallin R
Department of Pharmacology, University of Illinois at Chicago 60612, USA.
Biochem Pharmacol. 1998 Jan 15;55(2):169-75. doi: 10.1016/s0006-2952(97)00431-0.
Vitamin K1 oxide reductase activity has been partially purified from rat liver microsomes. A three-step procedure produced a preparation in which warfarin-sensitive vitamin K1 oxide reductase activity was 118-fold enriched over the activity in intact rat liver microsomes. A major component of the multi-protein mixture was identified as a 50 kDa protein that strongly cross-reacts with antiserum prepared against homogeneous rat liver microsomal epoxide hydrolase. The reductase preparation also had a high level or epoxide hydrolase activity against two xenobiotic epoxide substrates. The K(m) values for hydrolysis by the reductase preparation were similar to those for homogeneous microsomal epoxide hydrolase itself, and the specific hydrolase activities of the reductase preparation were 25-35% of the specific activities measured for the homogeneous hydrolase preparation. Antibodies prepared against homogeneous microsomal epoxide hydrolase inhibited up to 80% of reductase activity of the reductase preparation. Homogeneous microsomal epoxide hydrolase had no vitamin K1 oxide reductase activity. This evidence suggests that microsomal epoxide hydrolase, or a protein that is very similar to it, is a major functional component of a multi-protein complex that is responsible for vitamin K1 oxide reduction in rat liver microsomes.
维生素K1氧化还原酶活性已从大鼠肝脏微粒体中部分纯化出来。一个三步程序制备出了一种制剂,其中对华法林敏感的维生素K1氧化还原酶活性比完整大鼠肝脏微粒体中的活性富集了118倍。该多蛋白混合物的一个主要成分被鉴定为一种50 kDa的蛋白质,它与针对大鼠肝脏微粒体环氧水解酶纯品制备的抗血清发生强烈交叉反应。该还原酶制剂对两种外源性环氧化物底物也具有高水平的环氧水解酶活性。该还原酶制剂水解的K(m)值与微粒体环氧水解酶纯品本身的K(m)值相似,且该还原酶制剂的比水解活性为微粒体环氧水解酶纯品制剂所测比活性的25% - 35%。针对微粒体环氧水解酶纯品制备的抗体可抑制该还原酶制剂高达80%的还原酶活性。微粒体环氧水解酶纯品没有维生素K1氧化还原酶活性。这一证据表明,微粒体环氧水解酶或与其非常相似的一种蛋白质是负责大鼠肝脏微粒体中维生素K1氧化还原的多蛋白复合物的主要功能成分。